Orion Oyj (OHEL:ORNBV) Inventories, Finished Goods : €0 Mil (As of Mar. 2025)

View and export this data going back to 2006. Start your Free Trial

What is Orion Oyj Inventories, Finished Goods?

Orion Oyj's quarterly finished goods increased from Sep. 2024 (€0 Mil) to Dec. 2024 (€205 Mil) but then declined from Dec. 2024 (€205 Mil) to Mar. 2025 (€0 Mil).

Orion Oyj's annual finished goods increased from Dec. 2022 (€159 Mil) to Dec. 2023 (€181 Mil) and increased from Dec. 2023 (€181 Mil) to Dec. 2024 (€205 Mil).

Orion Oyj Inventories, Finished Goods Historical Data

The historical data trend for Orion Oyj's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orion Oyj Inventories, Finished Goods Chart

Orion Oyj Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Inventories, Finished Goods

Get a 7-Day Free Trial

161.20

151.70

159.30

180.50

204.60

Orion Oyj Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Inventories, Finished Goods	Get a 7-Day Free Trial															-	-	-	204.60	-

Orion Oyj Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Orion Oyj Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Orion Oyj (OHEL:ORNBV) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

ORINY:USA ORNBVh:UK 0M2O:UK 0M2N:UK ORNAV:Finland OFK:Germany

Address

Orionintie 1, Espoo, FIN, FI-02200

Website

https://www.orion.fi

Orion Oyj is a globally operating Finnish pharmaceutical company that develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients. The company predominantly focuses on treatments for central nervous system disorders, oncology, and respiratory diseases. Orion's customers include specialists and general practitioners, veterinarians, pharmacies, hospitals, and laboratories. Orion mainly serves Finland but also has a presence in other European countries, North America and other countries.

Orion Oyj Headlines

No Headlines